Histamin

Histamin Control is available as oral tablets, tailored to different weight categories of animals. Variants include Histamin Control (10, 60, 120 or 300 tablets) and Histamin Control Large Breed (8, 60 or 240 tablets), specially formulated for large breed dogs. 

This variety allows for easy administration and precise dosing, tailored to the individual needs of the veterinary patient.

Histamin Control is recommended for cases of food allergies, allergic dermatitis, urticaria, eczema, allergic rhinitis and bronchial asthma. It can also be used in situations where there is immune hyperreactivity, helping to regulate the immune response by reducing exaggerated reactions to allergens.

Its mechanisms of action are supported by the active ingredients: quercetin, a flavonoid with natural antihistamine properties; beta-glucans, which modulate the immune response by stimulating macrophages; nettle extract, with anti-inflammatory and decongestant effects; bromelain, with anti-inflammatory and oedema-reducing properties; MSM, which limits histamine binding at the tissue level. 

Histamin Control Stangest is administered orally, depending on the animal’s body weight. 

The recommended dose is 1 tablet per 10 kg of body weight, administered twice daily. For the large-breed variant, the dose is 1 tablet per 25 kg, twice daily.

Histamin Control for dogs and cats is not intended for human consumption and is contraindicated in animals with known hypersensitivity to any of the product’s components. 

Furthermore, it should be used with caution in animals with severe systemic conditions or in situations where complex concomitant treatments are being administered, and prior veterinary assessment is required.

An important aspect of using Histamin Control for cats and dogs is its nature as a dietary supplement, which implies a gradual action and the need for sustained administration to achieve optimal results. 

The product can also be integrated into complex treatment regimens, including in combination with conventional antihistamines or corticosteroids, helping to reduce their doses.

Histamin Control is generally well tolerated by dogs and cats, thanks to its composition based on natural ingredients. 

Mild digestive disturbances, such as diarrhoea or temporary abdominal discomfort, may rarely occur. Allergic reactions to the product’s components are possible but extremely rare.

The product can be used in combination with other drug therapies, including corticosteroids or synthetic antihistamines, with no major interactions reported. However, close monitoring of the patient is recommended, particularly when supplements or drugs with immunomodulatory effects are administered concurrently.

From a nutritional perspective, incorporating the product into a hypoallergenic diet may enhance the therapeutic effects.

No severe toxic effects have been reported in cases of overdose; however, administration of quantities greater than those recommended may increase the risk of adverse gastrointestinal reactions. In the absence of a specific antidote, management is symptomatic and consists of discontinuing administration and clinical monitoring of the animal.

The product must be stored in its original packaging at temperatures below 25°C, protected from moisture and direct light. It is essential that the product is kept out of the reach of children and animals to prevent accidental ingestion.

• Frontiers, Quercetin exhibits multi-targeted anti-allergic effects in animal models: a systematic review and meta-analysis of preclinical studies
• CABI Digital Library, Therapeutic effects of quercetin in a canine model of low-dose lipopolysaccharide-induced sepsis, compared with hydrocortisone
• MDPI, Anti-inflammatory and antioxidant effects of quercetin, luteolin and proanthocyanidins on canine peripheral blood mononuclear cells stimulated with Escherichia coli
• PubMed, Application of human and animal model studies to veterinary care of dogs and cats: the use of beta-glucans in the treatment of skin conditions, osteoarthritis and inflammatory bowel disease